Skip to main content
×
×
Home

Patient information leaflets on psychotropic drugs: opinions and use by psychiatrists

  • Sridhar Vaitheswaran (a1), Angela MacManus (a2) and Ross Hamilton (a3)
Abstract
Aims and Method

To assess circumstances and frequency of use, opinions and suggestions for improvement from psychiatrists in a teaching hospital on UK Psychiatric Pharmacy Group patient information leaflets for psychotropic drugs. We also sought information from psychiatrists regarding use of alternate sources of information provision for their patients on psychotropic drugs. A questionnaire was designed, piloted and distributed.

Results

Sixty-one psychiatrists were approached, of whom 49 (80%) responded. the most common indications for use were when initiating a new treatment and when information is sought by the individual or their carers. the most common reason for not using these leaflets was lack of awareness of their existence. Although 33 (67%) responders were of the opinion that these leaflets were useful for patients, only a small proportion was using them frequently.

Clinical Implications

Our study suggested increasing awareness among psychiatrists to encourage the use of patient information leaflets. Various other themes to improve their use also emerged including easy accessibility to the patient information leaflets, modification in the content and structure, and recording the provision of patient information leaflets in the case records.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Patient information leaflets on psychotropic drugs: opinions and use by psychiatrists
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Patient information leaflets on psychotropic drugs: opinions and use by psychiatrists
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Patient information leaflets on psychotropic drugs: opinions and use by psychiatrists
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
1 General Medical Council (GMC). Good Medical Practice. GMC, 2006 (http://www.gmc-uk.org/guidance/good_medical_practice/duties_of_a_doctor.asp).
2 Hamann, J, Langer, B, Winkler, V, Busch, R, Cohen, R, Leucht, S, et al. Shared decision making for in-patients with schizophrenia. Acta Psychiatr Scand 2006; 114: 265–73.
3 Schoen, C, Osborn, R, Huynh, PT, Doty, M, Davis, K, Zapert, K, et al. Primary care and health system performance: adults' experiences in five countries. Health Aff (Millwood) 2004; Suppl Web Exclusives W4: 487503 (http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.487v1.pdf).
4 Robinson, G, Merav, A. Informed consent: recall by patients tested postoperatively. Ann Thorac Surg 1976; 22: 209–12.
5 Weinman, I. Providing written information for patients: psychological consequences. JR Soc Med 1990; 83: 303–5.
6 Angunawela, I, Mullee, M. Drug information for the mentally ill: a randomized controlled trial. Int J Psych Clin Pract 1998; 2: 121–7.
7 Council Directive. Council Directive 92/27/EEC of 31 March 1992 on the labelling of medicinal products for human use and on package leaflets. Chapter III–User package Leaflet; April 30, 1992. Official J Eur Commun 1992; 113: 812.
8 Raynor, DK, Knapp, P. Do patients see read and retain the new mandatory medicines information leaflets? Pharm J 2000; 264: 268–70.
9 Clinical Standards Board for Scotland. Clinical Standards for Schizophrenia. Clinical Standards Board for Scotland, 2001.
10 British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary Number 51. BMJ Group & RPS Publishing Group, 2007.
11 Taylor, D, Paton, C, Kerwin, R. Maudsley Prescribing Guidelines, (9th edn). Informa Healthcare, 2007.
12 Bell, JS, Rosen, A, Aslani, P, Whitehead, P, Chen, TF. Developing the role of pharmacists as members of community mental health teams: perspectives of pharmacists and mental health professionals. Res Social Adm Pharm 2007; 3: 392409.
13 Desplenter, F, Simoens, S, Laekeman, G. The impact of informing psychiatric patients about their medication: a systematic review. Pharm World Sci 2006; 28: 329–41.
14 Al-Saffar, N, Deshmukh, AA, Carter, P, Adib, SM. Effect of information leaflets and counselling on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in Kuwait. Int J Pharm Pract 2005; 13: 123–31.
15 Peveller, R, George, C, Kinmonth, A-L, Campbell, M, Thomson, C. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ 1999; 319: 612–5.
16 Koo, MM, Krass, I, Aslani, P. Factors influencing consumer use of written drug information. Ann Pharmacother 2003; 37: 259–67.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 5 *
Loading metrics...

Abstract views

Total abstract views: 34 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 22nd July 2018. This data will be updated every 24 hours.

Patient information leaflets on psychotropic drugs: opinions and use by psychiatrists

  • Sridhar Vaitheswaran (a1), Angela MacManus (a2) and Ross Hamilton (a3)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *